Vivek Jain - 07 Mar 2026 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Chairman and CEO, Director
Signature: By: Paula Darbyshire, Attorney-in-Fact For: Vivek Jain
Issuer symbol: ICUI
Transactions as of: 07 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 16:21:34 UTC
Previous filing: 15 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jain Vivek	Chairman and CEO, Director	951 CALLE AMANECER, SAN CLEMENTE	By: Paula Darbyshire, Attorney-in-Fact For: Vivek Jain	08 Mar 2026	0001410442

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise		+5,282	+7.9%	$0.000000^*	71,790	07 Mar 2026	Direct	F1
transaction	ICUI	Common Stock	Tax liability		-2,919	-4.1%	$0.000000^*	68,871	07 Mar 2026	Direct
transaction	ICUI	Common Stock	Options Exercise		+107,635	+156%	$0.000000^*	176,506	08 Mar 2026	Direct	F2
transaction	ICUI	Common Stock	Tax liability		-59,500	-34%	$132.00^*	117,006	08 Mar 2026	Direct
holding	ICUI	Common Stock						152,339	07 Mar 2026	by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise		-5,282	-33%	$0.000000^*	10,566	07 Mar 2026	Common Stock	5,282		Direct	F1, F3, F4, F5
transaction	ICUI	Performance Shares	Options Exercise		-107,635	-100%	$0.000000^*	0	08 Mar 2026	Common Stock	107,635	$0.000000	Direct	F2, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are Restricted Stock Units.
F2	Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein.
F3	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5	These are restricted stock units that fully vest 3 years from the grant date.
F6	These Securities are Performance-based Restricted Stock Units (PRSU).
F7	There is neither a purchase price nor an exercise price for the PRSUs.